These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9700703)

  • 21. Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.
    Pellegrino P; Carnovale C; Perrone V; Pozzi M; Antoniazzi S; Radice S; Clementi E
    Vaccine; 2014 Aug; 32(37):4730-5. PubMed ID: 25000592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination in subjects with alpha1-antitrypsin deficiency.
    Campos MA; Alazemi S; Zhang G; Sandhaus RA; Wanner A
    Chest; 2008 Jan; 133(1):49-55. PubMed ID: 17908701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
    Olberg HK; Cox RJ; Nostbakken JK; Aarseth JH; Vedeler CA; Myhr KM
    Mult Scler; 2014 Jul; 20(8):1074-80. PubMed ID: 24436455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination in asthmatic children: effects on quality of life and symptoms.
    Bueving HJ; van der Wouden JC; Raat H; Bernsen RM; de Jongste JC; van Suijlekom-Smit LW; Osterhaus AD; Rimmelzwaan GF; Mölken MR; Thomas S
    Eur Respir J; 2004 Dec; 24(6):925-31. PubMed ID: 15572533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Swine influenza virus vaccination in patients with multiple sclerosis.
    Myers LW; Ellison GW; Lucia M; Novom S; Holevoet M; Madden D; Sever J; Noble GR
    J Infect Dis; 1977 Dec; 136 Suppl():S546-54. PubMed ID: 342627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.
    Miller AE; Morgante LA; Buchwald LY; Nutile SM; Coyle PK; Krupp LB; Doscher CA; Lublin FD; Knobler RL; Trantas F; Kelley L; Smith CR; La Rocca N; Lopez S
    Neurology; 1997 Feb; 48(2):312-4. PubMed ID: 9040712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reported adverse events following influenza vaccination].
    van Balveren-Slingerland L; Rümke HC; Kant AC
    Ned Tijdschr Geneeskd; 2014; 158():A6841. PubMed ID: 24518843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccination in paediatric nurses: cross-sectional study of coverage, refusal, and factors in acceptance.
    Norton SP; Scheifele DW; Bettinger JA; West RM
    Vaccine; 2008 Jun; 26(23):2942-8. PubMed ID: 18448210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety of influenza vaccination in asthmatics].
    Kmiecik T; Sek K; Górski P
    Pneumonol Alergol Pol; 2006; 74(4):365-71. PubMed ID: 17427144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumococcal vaccination for persons 65 years of age and older].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of adverse events after influenza vaccination in hospital personnel.
    Scheifele DW; Bjornson G; Johnston J
    CMAJ; 1990 Jan; 142(2):127-30. PubMed ID: 2295029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012-2013 influenza season.
    Maltezou HC; Fotiou A; Antonakopoulos N; Kallogriopoulou C; Katerelos P; Dimopoulou A; Tsoutsa V; Siahanidou T; Papagaroufalis C; Kostis E; Papantoniou N; Antsaklis A; Theodoridou M
    Clin Infect Dis; 2013 Dec; 57(11):1520-6. PubMed ID: 24046313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff.
    Lester RT; McGeer A; Tomlinson G; Detsky AS
    Infect Control Hosp Epidemiol; 2003 Nov; 24(11):839-44. PubMed ID: 14649772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal influenza vaccination in patients with COPD: a systematic literature review.
    Bekkat-Berkani R; Wilkinson T; Buchy P; Dos Santos G; Stefanidis D; Devaster JM; Meyer N
    BMC Pulm Med; 2017 May; 17(1):79. PubMed ID: 28468650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.
    Bettinger JA; Rouleau I; Gariepy MC; Bowie WR; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; McNeil SA; McCarthy A; De Serres G;
    Euro Surveill; 2015 Jul; 20(29):21189. PubMed ID: 26227369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada.
    Mahmud SM; Bozat-Emre S; Mostaço-Guidolin LC; Marrie RA
    Emerg Infect Dis; 2018 Jul; 24(7):1267-1274. PubMed ID: 29912696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.